Biofrontera (BFRI) Consolidated Net Income (2020 - 2026)

Biofrontera's Consolidated Net Income history runs 6 years deep, the most recent figure standing at $7.9 million for Q4 2025.

• In Q4 2025, Consolidated Net Income rose 663.9% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at -$8.3 million (up 53.24% YoY), while the FY2025 annual figure was -$8.3 million, up 53.24% from the prior year.
• Consolidated Net Income for Q4 2025 stood at $7.9 million, up from -$6.6 million in the prior quarter.
• The five-year high for Consolidated Net Income was $7.9 million in Q4 2025, with the low at -$16.0 million in Q3 2021.
• The 5-year median for Consolidated Net Income is -$3.9 million (2021), against an average of -$4.2 million.
• The sharpest annual moves came in 2021 and 2025: Consolidated Net Income slumped 7698.39% in 2021, then surged 663.9% in 2025.
• Biofrontera's Consolidated Net Income stood at -$14.5 million in 2021, then surged by 80.8% to -$2.8 million in 2022, then soared by 226.61% to $3.5 million in 2023, then sank by 139.59% to -$1.4 million in 2024, then soared by 663.9% to $7.9 million in 2025.
• Business Quant data shows BFRI's Consolidated Net Income at $7.9 million in Q4 2025, -$6.6 million in Q3 2025, and -$5.3 million in Q2 2025.